EDITAS MEDICINE, INC.
Last · NasdaqGS$2.27-0.175 (-7.16%)close · yahoo · 17h ago
Market cap$348.63M153.6M sh
P/E · TTM-4.3fwd -3.0 · eps -0.72 · loss
Beta2.00vs S&P 500
Div yield0.00%annual · TTM
52w range
$1.66$4.33
Volume2.8Msession
| Revenue | $14.7M |
|---|---|
| Operating income | $-43.6M |
| Net income | $-43.2M |
| Free cash flow | $-52.8M |
| Operating margin | -295.9% |
| Net margin | -293.5% |
| Return on equity | -41.0% |
| Period | 2026 |
Loading chart…
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.21
Est. revenue
4.5M
Earnings transcripts
- Issuer webcast
Click here for Webcast
EDITAS MEDICINE, INC.
- Issuer webcast
Click here for Webcast
EDITAS MEDICINE, INC.
- Issuer webcast
Click here for Webcast
EDITAS MEDICINE, INC.
- Issuer webcast
Click here for Webcast
EDITAS MEDICINE, INC.
- Issuer webcast
Click here for Webcast
EDITAS MEDICINE, INC.
- Issuer webcast
Click here for Webcast
EDITAS MEDICINE, INC.
Press & signals
- GlobeNewswire
Editas Medicine Reports Inducement Grants to New Chief Medical Officer
- GlobeNewswire
Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer
- GlobeNewswire
Editas Medicine Announces Second Quarter 2026 Results and Business Updates
The rest of this company's wire — with summaries and source links — is part of Pro.
See plans